APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Drug Delivery Formulation

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Injectable Drug Delivery Formulation Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchInjectable Drug Delivery Formulation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Drug Delivery Formulation Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Injectable Drug Delivery Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Drug Delivery Formulation Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Drug Delivery Formulation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Injectable Drug Delivery Formulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Drug Delivery Formulation include Teva Pharmaceutical Industries Ltd. (Israel), Sandoz (Germany), Eli Lilly and Company (US), Pfizer, Inc. (US), Baxter International Inc. (US), Schott AG (Germany), Gerresheimer AG (Germany) and Becton, Dickinson and Company (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Injectable Drug Delivery Formulation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Injectable Drug Delivery Formulation market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Injectable Drug Delivery Formulation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Injectable Drug Delivery Formulation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Injectable Drug Delivery Formulation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Injectable Drug Delivery Formulation Market by Company

Teva Pharmaceutical Industries Ltd. (Israel)

Sandoz (Germany)

Eli Lilly and Company (US)

Pfizer, Inc. (US)

Baxter International Inc. (US)

Schott AG (Germany)

Gerresheimer AG (Germany)

Becton, Dickinson and Company (US)

Injectable Drug Delivery Formulation Segment by Type

Conventional Drug Delivery Formulations

Novel Drug Delivery Formulations

Long-acting Formulations

Injectable Drug Delivery Formulation Segment by Application

Orphan Diseases

Hormonal Disorders

Oncology

Autoimmune Diseases

Others

Injectable Drug Delivery Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Drug Delivery Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Drug Delivery Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Drug Delivery Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Drug Delivery Formulation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Injectable Drug Delivery Formulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Conventional Drug Delivery Formulations Table 2. Major Company of Novel Drug Delivery Formulations Table 3. Major Company of Long-acting Formulations Table 4. Global Injectable Drug Delivery Formulation Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 6. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Type (2021-2026) Table 7. Global Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (US$ Million) Table 8. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Type (2021-2026) Table 9. Global Injectable Drug Delivery Formulation Price by Type (2021-2026) & (US$/unit) Table 10. Global Injectable Drug Delivery Formulation Sales by Type (2027-2032) & (k units) Table 11. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Type (2027-2032) Table 12. Global Injectable Drug Delivery Formulation Sales by Type (2027-2032) & (US$ Million) Table 13. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Type (2027-2032) Table 14. Global Injectable Drug Delivery Formulation Price by Type (2027-2032) & (US$/unit) Table 15. North America Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 16. North America Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 18. Europe Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 22. Latin America Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (US$ Million) Table 25. Injectable Drug Delivery Formulation Industry Trends Table 26. Injectable Drug Delivery Formulation Industry Drivers Table 27. Injectable Drug Delivery Formulation Industry Opportunities and Challenges Table 28. Injectable Drug Delivery Formulation Industry Restraints Table 29. Global Injectable Drug Delivery Formulation Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Injectable Drug Delivery Formulation Revenue Market Share by Company (2021-2026) Table 31. Global Injectable Drug Delivery Formulation Sales by Company (2021-2026) & (k units) Table 32. Global Injectable Drug Delivery Formulation Sales Share by Company (2021-2026) Table 33. Global Injectable Drug Delivery Formulation Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Injectable Drug Delivery Formulation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Injectable Drug Delivery Formulation Major Company Production Sites and Headquarters Table 36. Global Injectable Drug Delivery Formulation Company, Product Type & Application Table 37. Global Injectable Drug Delivery Formulation Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Injectable Drug Delivery Formulation Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Injectable Drug Delivery Formulation Sales by Region (2021-2026) & (k units) Table 42. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Region (2021-2026) Table 43. Global Injectable Drug Delivery Formulation Sales by Region (2021-2026) & (US$ Million) Table 44. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Region (2021-2026) Table 45. Global Injectable Drug Delivery Formulation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Injectable Drug Delivery Formulation Sales by Region (2027-2032) & (k units) Table 47. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Region (2027-2032) Table 48. Global Injectable Drug Delivery Formulation Sales by Region (2027-2032) & (US$ Million) Table 49. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Region (2027-2032) Table 50. Global Injectable Drug Delivery Formulation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Injectable Drug Delivery Formulation Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 53. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Application (2021-2026) Table 54. Global Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (US$ Million) Table 55. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Application (2021-2026) Table 56. Global Injectable Drug Delivery Formulation Price by Application (2021-2026) & (US$/unit) Table 57. Global Injectable Drug Delivery Formulation Sales by Application (2027-2032) & (k units) Table 58. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Application (2027-2032) Table 59. Global Injectable Drug Delivery Formulation Sales by Application (2027-2032) & (US$ Million) Table 60. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Application (2027-2032) Table 61. Global Injectable Drug Delivery Formulation Price by Application (2027-2032) & (US$/unit) Table 62. North America Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 63. North America Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 65. Europe Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 69. Latin America Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Industries Ltd. (Israel) Company Information Table 73. Teva Pharmaceutical Industries Ltd. (Israel) Business Overview Table 74. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Portfolio Table 76. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development Table 77. Sandoz (Germany) Company Information Table 78. Sandoz (Germany) Business Overview Table 79. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Sandoz (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 81. Sandoz (Germany) Recent Development Table 82. Eli Lilly and Company (US) Company Information Table 83. Eli Lilly and Company (US) Business Overview Table 84. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Portfolio Table 86. Eli Lilly and Company (US) Recent Development Table 87. Pfizer, Inc. (US) Company Information Table 88. Pfizer, Inc. (US) Business Overview Table 89. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Portfolio Table 91. Pfizer, Inc. (US) Recent Development Table 92. Baxter International Inc. (US) Company Information Table 93. Baxter International Inc. (US) Business Overview Table 94. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Portfolio Table 96. Baxter International Inc. (US) Recent Development Table 97. Schott AG (Germany) Company Information Table 98. Schott AG (Germany) Business Overview Table 99. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Schott AG (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 101. Schott AG (Germany) Recent Development Table 102. Gerresheimer AG (Germany) Company Information Table 103. Gerresheimer AG (Germany) Business Overview Table 104. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 106. Gerresheimer AG (Germany) Recent Development Table 107. Becton, Dickinson and Company (US) Company Information Table 108. Becton, Dickinson and Company (US) Business Overview Table 109. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Portfolio Table 111. Becton, Dickinson and Company (US) Recent Development Table 112. North America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 113. North America Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 114. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2026) Table 115. North America Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032) & (k units) Table 116. North America Injectable Drug Delivery Formulation Sales Market Share Forecast by Country (2027-2032) Table 117. North America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Injectable Drug Delivery Formulation Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Injectable Drug Delivery Formulation Market Share by Country (2021-2026) Table 120. North America Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Injectable Drug Delivery Formulation Market Share Forecast by Country (2027-2032) Table 122. Europe Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. Europe Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 124. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2026) Table 125. Europe Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032) & (k units) Table 126. Europe Injectable Drug Delivery Formulation Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Injectable Drug Delivery Formulation Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Injectable Drug Delivery Formulation Market Share by Country (2021-2026) Table 130. Europe Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Injectable Drug Delivery Formulation Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 134. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032) & (k units) Table 136. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Injectable Drug Delivery Formulation Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Injectable Drug Delivery Formulation Market Share by Country (2021-2026) Table 140. Asia-Pacific Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Injectable Drug Delivery Formulation Market Share Forecast by Country (2027-2032) Table 142. Latin America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Latin America Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 144. Latin America Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2026) Table 145. Latin America Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032) & (k units) Table 146. Latin America Injectable Drug Delivery Formulation Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Injectable Drug Delivery Formulation Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Injectable Drug Delivery Formulation Market Share by Country (2021-2026) Table 150. Latin America Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Injectable Drug Delivery Formulation Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032) & (k units) Table 156. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Injectable Drug Delivery Formulation Market Share by Country (2021-2026) Table 160. Middle East and Africa Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Injectable Drug Delivery Formulation Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Injectable Drug Delivery Formulation Distributors List Table 165. Injectable Drug Delivery Formulation Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Injectable Drug Delivery Formulation Image Figure 2. Global Injectable Drug Delivery Formulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Drug Delivery Formulation Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Drug Delivery Formulation Sales (2021-2032) & (k units) Figure 5. Conventional Drug Delivery Formulations Image Figure 6. Global Conventional Drug Delivery Formulations Sales YoY Growth (2021-2032) & (k units) Figure 7. Novel Drug Delivery Formulations Image Figure 8. Global Novel Drug Delivery Formulations Sales YoY Growth (2021-2032) & (k units) Figure 9. Long-acting Formulations Image Figure 10. Global Long-acting Formulations Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Injectable Drug Delivery Formulation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Injectable Drug Delivery Formulation Market Share by Type 2025 VS 2032 Figure 13. North America Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2025 Figure 14. North America Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2025 Figure 15. Europe Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2025 Figure 16. Europe Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2025 Figure 19. Latin America Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Injectable Drug Delivery Formulation Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Orphan Diseases Image Figure 26. Global Orphan Diseases Sales YoY Growth (2021-2032) & (k units) Figure 27. Hormonal Disorders Image Figure 28. Global Hormonal Disorders Sales YoY Growth (2021-2032) & (k units) Figure 29. Oncology Image Figure 30. Global Oncology Sales YoY Growth (2021-2032) & (k units) Figure 31. Autoimmune Diseases Image Figure 32. Global Autoimmune Diseases Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Injectable Drug Delivery Formulation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Injectable Drug Delivery Formulation Market Share by Application 2025 VS 2032 Figure 37. North America Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2025 Figure 38. North America Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2025 Figure 39. Europe Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2025 Figure 40. Europe Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2025 Figure 43. Latin America Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2025 Figure 47. North America Injectable Drug Delivery Formulation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Injectable Drug Delivery Formulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Injectable Drug Delivery Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Injectable Drug Delivery Formulation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Injectable Drug Delivery Formulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Injectable Drug Delivery Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Injectable Drug Delivery Formulation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Injectable Drug Delivery Formulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Injectable Drug Delivery Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Injectable Drug Delivery Formulation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Injectable Drug Delivery Formulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Injectable Drug Delivery Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Injectable Drug Delivery Formulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Injectable Drug Delivery Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Injectable Drug Delivery Formulation Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Injectable Drug Delivery Formulation Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Conventional Drug Delivery Formulations
  • Novel Drug Delivery Formulations
  • Long-acting Formulations
Applications
  • Orphan Diseases
  • Hormonal Disorders
  • Oncology
  • Autoimmune Diseases
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sandoz (Germany)
  • Eli Lilly and Company (US)
  • Pfizer, Inc. (US)
  • Baxter International Inc. (US)
  • Schott AG (Germany)
  • Gerresheimer AG (Germany)
  • Becton, Dickinson and Company (US)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injectable Drug Delivery Formulation Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Injectable Drug Delivery Formulation Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Injectable Drug Delivery Formulation Market by Type
  6. 1.3.1 Conventional Drug Delivery Formulations
  7. 1.3.2 Novel Drug Delivery Formulations
  8. 1.3.3 Long-acting Formulations
  9. 1.4 Global Injectable Drug Delivery Formulation Market Size by Type
  10. 1.4.1 Global Injectable Drug Delivery Formulation Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Injectable Drug Delivery Formulation Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Injectable Drug Delivery Formulation Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Injectable Drug Delivery Formulation Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Injectable Drug Delivery Formulation Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Injectable Drug Delivery Formulation Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Injectable Drug Delivery Formulation Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Injectable Drug Delivery Formulation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Injectable Drug Delivery Formulation Industry Trends
  2. 2.2 Injectable Drug Delivery Formulation Industry Drivers
  3. 2.3 Injectable Drug Delivery Formulation Industry Opportunities and Challenges
  4. 2.4 Injectable Drug Delivery Formulation Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Injectable Drug Delivery Formulation Revenue (2021-2026)
  2. 3.2 Global Top Players by Injectable Drug Delivery Formulation Sales (2021-2026)
  3. 3.3 Global Top Players by Injectable Drug Delivery Formulation Price (2021-2026)
  4. 3.4 Global Injectable Drug Delivery Formulation Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Drug Delivery Formulation Major Company Production Sites & Headquarters
  6. 3.6 Global Injectable Drug Delivery Formulation Company, Product Type & Application
  7. 3.7 Global Injectable Drug Delivery Formulation Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Drug Delivery Formulation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Drug Delivery Formulation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Drug Delivery Formulation Tier 1, Tier 2, and Tier 3
4 Injectable Drug Delivery Formulation Regional Status and Outlook
  1. 4.1 Global Injectable Drug Delivery Formulation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Injectable Drug Delivery Formulation Historic Market Size by Region
  3. 4.2.1 Global Injectable Drug Delivery Formulation Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Injectable Drug Delivery Formulation Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Injectable Drug Delivery Formulation Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Injectable Drug Delivery Formulation Forecasted Market Size by Region
  7. 4.3.1 Global Injectable Drug Delivery Formulation Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Injectable Drug Delivery Formulation Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Injectable Drug Delivery Formulation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Injectable Drug Delivery Formulation by Application
  1. 5.1 Injectable Drug Delivery Formulation Market by Application
  2. 5.1.1 Orphan Diseases
  3. 5.1.2 Hormonal Disorders
  4. 5.1.3 Oncology
  5. 5.1.4 Autoimmune Diseases
  6. 5.1.5 Others
  7. 5.2 Global Injectable Drug Delivery Formulation Market Size by Application
  8. 5.2.1 Global Injectable Drug Delivery Formulation Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Injectable Drug Delivery Formulation Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Injectable Drug Delivery Formulation Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Injectable Drug Delivery Formulation Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Injectable Drug Delivery Formulation Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Injectable Drug Delivery Formulation Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Injectable Drug Delivery Formulation Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Injectable Drug Delivery Formulation Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries Ltd. (Israel)
  2. 6.1.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments
  7. 6.2 Sandoz (Germany)
  8. 6.2.1 Sandoz (Germany) Company Information
  9. 6.2.2 Sandoz (Germany) Business Overview
  10. 6.2.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz (Germany) Injectable Drug Delivery Formulation Product Portfolio
  12. 6.2.5 Sandoz (Germany) Recent Developments
  13. 6.3 Eli Lilly and Company (US)
  14. 6.3.1 Eli Lilly and Company (US) Company Information
  15. 6.3.2 Eli Lilly and Company (US) Business Overview
  16. 6.3.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Portfolio
  18. 6.3.5 Eli Lilly and Company (US) Recent Developments
  19. 6.4 Pfizer, Inc. (US)
  20. 6.4.1 Pfizer, Inc. (US) Company Information
  21. 6.4.2 Pfizer, Inc. (US) Business Overview
  22. 6.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
  24. 6.4.5 Pfizer, Inc. (US) Recent Developments
  25. 6.5 Baxter International Inc. (US)
  26. 6.5.1 Baxter International Inc. (US) Company Information
  27. 6.5.2 Baxter International Inc. (US) Business Overview
  28. 6.5.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
  30. 6.5.5 Baxter International Inc. (US) Recent Developments
  31. 6.6 Schott AG (Germany)
  32. 6.6.1 Schott AG (Germany) Company Information
  33. 6.6.2 Schott AG (Germany) Business Overview
  34. 6.6.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Schott AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
  36. 6.6.5 Schott AG (Germany) Recent Developments
  37. 6.7 Gerresheimer AG (Germany)
  38. 6.7.1 Gerresheimer AG (Germany) Company Information
  39. 6.7.2 Gerresheimer AG (Germany) Business Overview
  40. 6.7.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
  42. 6.7.5 Gerresheimer AG (Germany) Recent Developments
  43. 6.8 Becton, Dickinson and Company (US)
  44. 6.8.1 Becton, Dickinson and Company (US) Company Information
  45. 6.8.2 Becton, Dickinson and Company (US) Business Overview
  46. 6.8.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Portfolio
  48. 6.8.5 Becton, Dickinson and Company (US) Recent Developments
7 North America by Country
  1. 7.1 North America Injectable Drug Delivery Formulation Sales by Country
  2. 7.1.1 North America Injectable Drug Delivery Formulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Injectable Drug Delivery Formulation Sales by Country (2021-2026)
  4. 7.1.3 North America Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032)
  5. 7.2 North America Injectable Drug Delivery Formulation Market Size by Country
  6. 7.2.1 North America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Injectable Drug Delivery Formulation Market Size by Country (2021-2026)
  8. 7.2.3 North America Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Injectable Drug Delivery Formulation Sales by Country
  2. 8.1.1 Europe Injectable Drug Delivery Formulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Injectable Drug Delivery Formulation Sales by Country (2021-2026)
  4. 8.1.3 Europe Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Injectable Drug Delivery Formulation Market Size by Country
  6. 8.2.1 Europe Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Injectable Drug Delivery Formulation Market Size by Country (2021-2026)
  8. 8.2.3 Europe Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Injectable Drug Delivery Formulation Sales by Country
  2. 9.1.1 Asia-Pacific Injectable Drug Delivery Formulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Injectable Drug Delivery Formulation Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Injectable Drug Delivery Formulation Market Size by Country
  6. 9.2.1 Asia-Pacific Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Injectable Drug Delivery Formulation Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Injectable Drug Delivery Formulation Sales by Country
  2. 10.1.1 South America Injectable Drug Delivery Formulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Injectable Drug Delivery Formulation Sales by Country (2021-2026)
  4. 10.1.3 South America Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032)
  5. 10.2 South America Injectable Drug Delivery Formulation Market Size by Country
  6. 10.2.1 South America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Injectable Drug Delivery Formulation Market Size by Country (2021-2026)
  8. 10.2.3 South America Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country
  2. 11.1.1 Middle East and Africa Injectable Drug Delivery Formulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Injectable Drug Delivery Formulation Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country
  6. 11.2.1 Middle East and Africa Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Injectable Drug Delivery Formulation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Injectable Drug Delivery Formulation Value Chain Analysis
  2. 12.1.1 Injectable Drug Delivery Formulation Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Injectable Drug Delivery Formulation Production Mode & Process
  7. 12.2 Injectable Drug Delivery Formulation Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Injectable Drug Delivery Formulation Distributors
  10. 12.2.3 Injectable Drug Delivery Formulation Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst